Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Profiling Biomarkers in HIV Glomerular Disease - Potential for the Non-Invasive Diagnosis of HIVAN? | Int J Nephrol Renovasc Dis | 2021 | 34916827 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. | Cell | 2021 | 34914922 | PubTator, text mining | PubMed |
| Tubular Injury Causing Protracted Glycosuria Following Withdrawal of a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor: A Possible Role in the Development of Protracted Hypoglycemia and Ketoacidosis. | Tohoku J Exp Med | 2021 | 34911880 | PubTator, text mining | PubMed |
| Transcriptomics of single dose and repeated carbon black and ozone inhalation co-exposure highlight progressive pulmonary mitochondrial dysfunction. | Part Fibre Toxicol | 2021 | 34911549 | PubTator, text mining | PubMed |
| Nanofat: A therapeutic paradigm in regenerative medicine. | World J Stem Cells | 2021 | 34909120 | PubTator, text mining | PubMed |
| The potential for artificial intelligence to predict clinical outcomes in patients who have acquired acute kidney injury during the perioperative period. | Perioper Med (Lond) | 2021 | 34906249 | PubTator, text mining | PubMed |
| Colon Cancer-Related Genes Identification and Function Study Based on Single-Cell Multi-Omics Integration. | Front Cell Dev Biol | 2021 | 34901030 | PubTator, text mining | PubMed |
| Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy. | Front Oncol | 2021 | 34888248 | PubTator, text mining | PubMed |
| The Many Faces of Lipids in Genome Stability (and How to Unmask Them). | Int J Mol Sci | 2021 | 34884734 | PubTator, text mining | PubMed |
| Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review. | Int J Mol Sci | 2021 | 34884570 | PubTator, text mining | PubMed |
| Effect of a 3% gelatin solution on urinary KIM-1 levels in patients after thyroidectomy: a preliminary randomized controlled trial. | Sci Rep | 2021 | 34880372 | PubTator, text mining | PubMed |
| Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology. | Biomed Res Int | 2021 | 34873575 | PubTator, text mining | PubMed |
| Wearing a face mask during controlled-intensity exercise is not a risk factor for exertional heatstroke: A pilot study. | Acute Med Surg | 2021 | 34868603 | PubTator, text mining | PubMed |
| Effects of Diminished NADPH:cytochrome P450 Reductase in Human Hepatocytes on Lipid and Bile Acid Homeostasis. | Front Pharmacol | 2021 | 34867397 | PubTator, text mining | PubMed |
| Adipocytokines as Risk Factors for Development of Nonalcoholic Fatty Liver Disease in Children. | J Clin Exp Hepatol | 2021 | 34866842 | PubTator, text mining | PubMed |
| Integrated omics analysis reveals sirtuin signaling is central to hepatic response to a high fructose diet. | BMC Genomics | 2021 | 34861817 | PubTator, text mining | PubMed |
| Urinary mRNA Signatures as Predictors of Renal Function Decline in Patients With Biopsy-Proven Diabetic Kidney Disease. | Front Endocrinol (Lausanne) | 2021 | 34858345 | PubTator, text mining | PubMed |
| Multiplex Serum Biomarker Assays Improve Prediction of Renal and Mortality Outcomes in Chronic Kidney Disease. | Kidney360 | 2021 | 34849485 | PubTator, text mining | PubMed |
| Lipid raft-disrupting miltefosine preferentially induces the death of colorectal cancer stem-like cells. | Clin Transl Med | 2021 | 34841679 | PubTator, text mining | PubMed |
| Microchip Immunoassays for Monitoring Renal Function: Rapid, Low-Cost, and Highly Sensitive Quantification of Urinary Biomarkers of Diabetic Nephropathy. | Micromachines (Basel) | 2021 | 34832765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=53